KJ Biosciences LLC is a private biotechnology company engaged in development of novel nanoparticle protein technologies for new and improved vaccines and related biologics products.
We aim for original and market-differentiating technologies and products. The company has successfully obtained competitive NIH SBIR grants/contracts for development of novel vaccines including universal influenza vaccine and bacterial conjugate vaccines based on the company’s proprietary nanoparticle protein technologies. The company also develops and provides novel research reagents including specialty antibodies to serve the research community. The company personnel are highly experienced in vaccine R&D, nanoparticle protein carriers, polysaccharides, conjugation, and formulation/delivery technologies.
We aim for original and market-differentiating technologies and products. The company has successfully obtained competitive NIH SBIR grants/contracts for development of novel vaccines including universal influenza vaccine and bacterial conjugate vaccines based on the company’s proprietary nanoparticle protein technologies. The company also develops and provides novel research reagents including specialty antibodies to serve the research community. The company personnel are highly experienced in vaccine R&D, nanoparticle protein carriers, polysaccharides, conjugation, and formulation/delivery technologies.
To discover and develop..., there is no expert on unknown™